Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-07-18
2006-07-18
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C426S321000, C426S534000, C426S590000, C426S599000, C536S018100, C549S275000
Reexamination Certificate
active
07078386
ABSTRACT:
The present invention relates to a medicament, a food, a beverage or a feed, each comprising as an effective ingredient a compound having an enhancing action for NGF production, which is effective for a treatment, an amelioration of symptom, prevention or the like of a disease requiring enhancement of NGF production, wherein the compound has a coumarin and/or chroman backbone. Since no toxicity is especially found in the effective ingredient of the present invention, and there is no risk of incidence of adverse actions, the treatment or the like of the above disease can be safely and appropriately carried out.
REFERENCES:
patent: 5639737 (1997-06-01), Rubin
patent: 5641789 (1997-06-01), Marfat
patent: 6475544 (2002-11-01), Hiramoto et al.
patent: 1163760 (1997-11-01), None
patent: 0 515 917 (1992-12-01), None
patent: 1 277 473 (2003-01-01), None
patent: 1 283 037 (2003-02-01), None
patent: 4-210643 (1992-07-01), None
Robert D. Terry et al.; Ann. Rev. Neurosci., 1980 vol. 3, pp. 77-95.
S. Korsching et al.; The EMBO Journal, vol. 4, No. 6, pp. 1389-1393, 1985.
Jean L. Marx, Science, vol. 232, Jun. 13, 1986, pp. 1341-1342.
Franz Hefti; The Journal of Neuroscience, Aug. 1986, No. 6(8), pp. 2155-2162.
F. Hefti et al.; Brain Research, vol. 293, 1984, pp. 305-311.
Lawrence F. Kromer; Science, vol. 235, Jan. 9, 1987, pp. 214-216.
Lawrence R. Williams et al.; Proc. Natl. Accad. Sci., vol. 83, pp. 9231-9235, Dec. 1986, pp. 9231-9235.
Yoshiko Furukawa et al.; The Journal of Biological Chemistry; vol. 259, No. 2, Issue of Jan. 25, 1984; pp. 1259-1264.
Shoei Furukawa et al.; Biochemical and Biophysical Research Communications; vol. 136, No. 1, Apr. 14, 1986, pp. 57-63.
Yoshiko Furukawa et al.; The Journal of BIological Chemistry; vol. 261, No. 13, Issue of May 5, 1986, pp. 6039-6047.
Murase Katsuhito et al,Biosci. Biotech. Biochem., 58(5), 900-905, 1994.
Velasco Lara et al.,Eur. J. Biochem., 268, 531-535 (2001).
Kato Ikunoshin
Ohnogi Hiromu
Sagawa Hiroaki
Shiraga Masahiro
Birch & Stewart Kolasch & Birch, LLP
Peselev Elli
Takara Bio Inc.
LandOfFree
Enhancing agent for nerve growth factor production... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancing agent for nerve growth factor production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing agent for nerve growth factor production... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3601401